Literature DB >> 30374250

Effects of Rehabilitation on Gait Pattern at Usual and Fast Speeds Depend on Walking Impairment Level in Multiple Sclerosis.

Carmela Leone, Alon Kalron, Tori Smedal, Britt Normann, Inez Wens, Bert O Eijnde, Peter Feys.   

Abstract

BACKGROUND: Physical rehabilitation can improve walking capacity in persons with multiple sclerosis (MS). However, changes in spatiotemporal gait parameters after rehabilitation are not frequently evaluated, and it is unknown to what extent potential effects depend on baseline disability level. The objective was to investigate the effectiveness of rehabilitation programs on gait parameters at usual and fastest speeds in persons with MS categorized according to walking speed.
METHODS: This nonrandomized multinational study in "real-world" settings evaluated participants before and after conventional rehabilitation. Outcome measurements included spatiotemporal gait parameters assessed by an electronic walkway (at usual and fastest speeds), walking capacity tests (Timed 25-Foot Walk test, 2-Minute Walk Test, 6-Minute Walk Test), and the patient-reported 12-item Multiple Sclerosis Walking Scale. Patients were allocated into three subgroups based on walking speed (<0.82 m/s and >1.14 m/s) and MS center. Results were calculated for the total group and subgroups.
RESULTS: Forty-two persons with MS (26 women; mean ± SD age, 44.6 ± 11.0 years; mean ± SD Expanded Disability Status Scale score, 3.5 ± 1.5) receiving rehabilitation treatment were enrolled. After rehabilitation treatment, the group demonstrated a significant decrease in double support time and an increase in stride length and step length (left leg) at usual and fastest speeds. Velocity and step length (right leg) increased only at usual speed. Subgroup analysis revealed greatest and clinically meaningful improvements in more disabled persons with MS.
CONCLUSIONS: Physical rehabilitation induced changes in spatiotemporal gait parameters in persons with MS. The magnitude of improvement was greater in participants with more walking impairment.

Entities:  

Year:  2018        PMID: 30374250      PMCID: PMC6200116          DOI: 10.7224/1537-2073.2015-078

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  30 in total

1.  Quantifying gait abnormalities in persons with multiple sclerosis with minimal disability.

Authors:  Jacob J Sosnoff; Brian M Sandroff; Robert W Motl
Journal:  Gait Posture       Date:  2012-03-17       Impact factor: 2.840

2.  Effects of long-term resistance training and simultaneous electro-stimulation on muscle strength and functional mobility in multiple sclerosis.

Authors:  Tom Broekmans; Machteld Roelants; Peter Feys; Geert Alders; Domien Gijbels; Ine Hanssen; Piet Stinissen; Bert O Eijnde
Journal:  Mult Scler       Date:  2010-12-09       Impact factor: 6.312

3.  Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trial.

Authors:  Rosaria Sacco; Rita Bussman; Peter Oesch; Jürg Kesselring; Serafin Beer
Journal:  J Neurol       Date:  2010-11-15       Impact factor: 4.849

4.  Can aerobic treadmill training reduce the effort of walking and fatigue in people with multiple sclerosis: a pilot study.

Authors:  M A Newman; H Dawes; M van den Berg; D T Wade; J Burridge; H Izadi
Journal:  Mult Scler       Date:  2007-01       Impact factor: 6.312

5.  Effect of exercise training on walking mobility in multiple sclerosis: a meta-analysis.

Authors:  Erin M Snook; Robert W Motl
Journal:  Neurorehabil Neural Repair       Date:  2008-10-23       Impact factor: 3.919

6.  Multiple sclerosis; earning a living.

Authors:  L Scheinberg; N Holland; N Larocca; P Laitin; A Bennett; H Hall
Journal:  N Y State J Med       Date:  1980-08

7.  Classification of walking handicap in the stroke population.

Authors:  J Perry; M Garrett; J K Gronley; S J Mulroy
Journal:  Stroke       Date:  1995-06       Impact factor: 7.914

8.  The effects of home-based resistance exercise on balance, power, and mobility in adults with multiple sclerosis.

Authors:  Louisa S DeBolt; Jeffrey A McCubbin
Journal:  Arch Phys Med Rehabil       Date:  2004-02       Impact factor: 3.966

9.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

10.  Quantifying gait impairment using an instrumented treadmill in people with multiple sclerosis.

Authors:  Alon Kalron; Zeevi Dvir; Lior Frid; Anat Achiron
Journal:  ISRN Neurol       Date:  2013-06-25
View more
  4 in total

1.  Efficacy of prolonged-release fampridine versus placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCE.

Authors:  Raymond Hupperts; Claudio Gasperini; Jan Lycke; Tjalf Ziemssen; Peter Feys; Shan Xiao; Carlos Acosta; Thijs Koster; Jeremy Hobart
Journal:  Ther Adv Neurol Disord       Date:  2022-05-18       Impact factor: 6.430

2.  What gait features influence the amount and intensity of physical activity in people with multiple sclerosis?

Authors:  Massimiliano Pau; Micaela Porta; Giancarlo Coghe; Eleonora Cocco
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

Review 3.  Review-Emerging Portable Technologies for Gait Analysis in Neurological Disorders.

Authors:  Christina Salchow-Hömmen; Matej Skrobot; Magdalena C E Jochner; Thomas Schauer; Andrea A Kühn; Nikolaus Wenger
Journal:  Front Hum Neurosci       Date:  2022-02-03       Impact factor: 3.169

4.  Sensor-based gait analyses of the six-minute walk test identify qualitative improvement in gait parameters of people with multiple sclerosis after rehabilitation.

Authors:  Pål Berg-Hansen; Stine Marit Moen; Andreas Austeng; Victor Gonzales; Thomas Dahl Klyve; Henrik Negård; Trine Margrethe Seeberg; Elisabeth Gulowsen Celius; Frédéric Meyer
Journal:  J Neurol       Date:  2022-02-15       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.